Skip to main content
. 2021 Mar 21;9(3):319. doi: 10.3390/biomedicines9030319

Figure 5.

Figure 5

Summary of immunotherapy treatments. Blockage of CTLA-4, PD-1, and PD-L1 promotes an effective immune response against cancer cells.